Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-01 Sale |
2021-07-01 5:20 pm |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
1,164 | $5.55 | $6,460 | 0 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 5:10 pm |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
3,628 | $9.474 | $34,372 | 90,697 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 5:34 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
3,750 | $12.05 | $45,188 | 321,711 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-10 5:29 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
3,750 | $13.04 | $48,900 | 325,461 (Direct) |
View |
| 2020-11-16 Sale(A) |
2021-02-10 5:28 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
5,990 | $8.7743 | $52,558 | 329,211 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 4:33 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
5,990 | $8.7743 | $52,558 | 339,211 (Direct) |
View |
| 2020-10-19 Sale |
2020-10-19 6:36 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
5,673 | $8.75 | $49,639 | 335,201 (Direct) |
View |
| 2020-10-15 Sale |
2020-10-16 4:39 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
317 | $8.75 | $2,774 | 340,874 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-16 08:32 am |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
5,990 | $10.39 | $62,236 | 341,191 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 4:35 pm |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
15,750 | $13 | $204,750 | 199,437 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 4:33 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
5,990 | $12.59 | $75,414 | 347,181 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 4:03 pm |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
159,327 | $13.1 | $2,086,396 | 1,274,616 (Indirect) |
View |
| 2020-07-15 Sale |
2020-07-17 4:11 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
5,990 | $11.85 | $70,982 | 353,171 (Direct) |
View |
| 2020-07-07 Sale |
2020-07-07 7:33 pm |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
1,753 | $11.72 | $20,538 | 0 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-06 4:00 pm |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
4,627 | $11.01 | $50,966 | 1,433,943 (Indirect) |
View |
| 2020-06-23 Sale |
2020-06-25 8:38 pm |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
154,700 | $11.11 | $1,718,568 | 1,438,570 (Indirect) |
View |
| 2020-06-15 Sale |
2020-06-16 4:53 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
5,990 | $8.75 | $52,413 | 359,161 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-09 Option Award |
2021-09-10 5:30 pm |
N/A 2031-09-08 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:39 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:31 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:30 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:30 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | SHARP PHILLIP A Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:29 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:28 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:27 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:24 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
17,500 | $0 | 17,500 (Direct) |
View |
Ownership |
2021-06-10 5:23 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
0 | $0 | 407,832 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 5:10 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
3,628 | $1.01 | 90,697 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 5:10 pm |
N/A 2023-05-22 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
3,628 | $0 | 90,697 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:16 pm |
N/A 2031-02-16 |
Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer |
94,000 | $0 | 94,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:15 pm |
N/A 2031-02-16 |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Admin. Officer |
94,000 | $0 | 94,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:14 pm |
N/A 2031-02-16 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
94,000 | $0 | 94,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:13 pm |
N/A 2031-02-16 |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
119,000 | $0 | 119,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:12 pm |
N/A 2031-02-16 |
Syros Pharmaceuticals Inc. | SYRS | Ferra Joseph J Jr Chief Financial Officer |
119,000 | $0 | 119,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:10 pm |
N/A 2031-02-16 |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
304,000 | $0 | 304,000 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-21 4:58 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
4,988 | $10.09 | 944,307 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-21 4:58 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
10,761 | $3.04 | 944,307 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-21 4:58 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
14,168 | $8.51 | 944,307 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-21 4:58 pm |
N/A 2025-06-08 |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
29,917 | $0 | 944,307 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-11 8:52 pm |
2021-06-08 2025-12-08 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
781,250 | $0 | 2,055,866 (Indirect) |
View |
| 2020-09-08 Option Award |
2020-09-09 08:51 am |
N/A 2030-09-07 |
Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 4:35 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
15,750 | $1.01 | 199,437 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 4:35 pm |
N/A 2023-05-22 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
15,750 | $0 | 199,437 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-11 4:54 pm |
N/A 2030-06-10 |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
17,500 | $0 | 17,500 (Direct) |
View |